Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 1, 1998, Pages 39-42

  Li, Chung Chen ^a   Chiu, Cheng Hsun ^a   Wu, Jue Lan ^b   Huang, Yhu Chering ^a   Lin, Tzou Yien ^a  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; NALIDIXIC ACID; QUINOLONE DERIVATIVE; TETRACYCLINE;

ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CHICKEN; CROSS RESISTANCE; FECES; HUMAN; HUMAN TISSUE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POULTRY; TAIWAN;

ANIMALS; CAMPYLOBACTER COLI; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; POULTRY; TAIWAN;

EID: 0031809217     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655498750002286     Document Type: Article

References (28)

1. Skirrow MB. A demographic survey of Campylobacter, Salmonella and Shigella infections in England. Epidemiol Infect 1987; 99: 547-57.
2. Blaster MJ, Wells JG, Feldman RA, Pollard RA, Allen JR. Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med 1983; 98: 360-5.
3. Ho BSW, Wong WT. A one-year survey of Campylobacter enteritis and other forms of bacterial diarrhea in Hong Kong. J Hyg 1985; 94: 55-60.
4. Zaman R. Campylobacter enteritis in Saudi Arabia. Epidemiol Infect 1992; 108: 51-8.
5. McNoulty CAM. The treatment of Campylobacter infections in man. J Antimicrob Chemother 1987; 19: 281-4.
6. Willians DM, Schorling JB. Barrett LJ, Dudley SM, Orgel J, Koch Weet, et al. Early treatment of Campylobacter jejuni enteritis. Antimicrob Agents Chemother 1989; 33: 248-50.
7. Sánchez R, Ferrández-Baca V, Diaz MD, Muñoz P, Rodríguez-Créixems M, Bouza E. Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob Agents Chemother 1994; 38: 1879-82.
8. Rautelin H, Renkonen OV, Kosunen TU. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother 1991; 35: 2065-9.
9. Sjögren E, Katjser B, Werner M. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10 year follow-up report. Antimicrob Agents Chemother 1992; 36: 2847-9.
10. Reina J, Ros MJ, Serra A. Susceptibilities to 10 antimicrobial agents of 1220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob Agents Chemother 1994; 38: 2917-20.
11. Penner JL. Campylobacter, Helicobacter. and related spiral bacteria. In: Balows A, Hausler Jr WJ, Herrmann KL, Isenberg HD, Shadomy HJ. editors. Manual of clinical microbiology, 5th edn. Washington, DC: American Society for Microbiology 1991; 402-9.
12. Performance standards for antimicrobial susceptibilities testing. M7-A3. Villanova, PA: National Committee for Clinical Laboratory Standards 1995.
13. Wang W-L L, Reller LB, Blaser MJ. Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 1984: 26: 151-3.
14. Blaser MJ, Relier LB, Campylobacter enteritis. N Engl J Med 1981; 305: 1444-52.
15. Goossens H, Mol De P, Coignau H, Levy J, Grades O, Ghysels G, et al. Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin. HR 810 (a new cephalosporin), RV 28965 (a new macrolide), and other agents against enteropathogens. Antimicrob Agents Chemother 1985; 27: 388-92.
16. Segreti J, Nelson JA, Goodman LJ, Kaplan RL, Trenholme GM. In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea. Antimicrob Agents Chemother 1989; 33: 1385-7.
17. Goodman LJ, Trenholme GM, Kaplan RL, Segreti J, Hines D, Petrak R, et al. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med 1990; 150: 541-6.
18. Reina J, Aloman P. Fluoroquinolone-resistance in thermophilic Campylobacter spp. isolated from stools of Spanish patients. Lancet 1990; 336: 186.
19. Endtz HPh, Mouton RP, Van Der Reyden T, Ruijs GJ, Biever M, Van Klingeren B. Fluoroquinolone resistance in Campylobacter spp. isolated from human stools and poultry products. Lancet 1990; 335: 787.
20. Gootz TD, Martin BA. Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrob Agents Chemother 1991; 35: 840-5.
21. Taylor DE, Ng L-K, Lior H. Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other gyrase inhibitors. Antimicrob Agents Chemother 1985; 28: 708-10.
22. Taylor DE, De Grandis SA, Karmali MA, Fleming PC. Transmissible plasmids from Campylobacter jejuni. Antimicrob Agents Chemother 1980; 19: 831-5.
23. Michel J, Rogol M, Dickman D. Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents. Antimicrob Agents Chemother 1983; 23: 796-7.
24. Baker CN, Stocker SA, Culver DH, Thornsberry C. Comparison of the E-test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J Clin Microbiol 1991; 29: 533-8.
25. Citron DM, Ostovari MI, Karlsson A, Goldstein EJC. Evaluation of the E-test for susceptibility testing of anaerobic bacteria. J Clin Microbiol 1991; 29: 2197-203.
26. Jacobs MR, Bajaksouzian S, Applebaum PC, Bolmstrom. Evaluation of the E-test for susceptibility testing of pneumococci. Diagn Microbiol Infect Dis 1992; 15: 473-8.
27. Baker CN. The E-test and Campylobacter jejuni. Diagn Microbiol Infect Dis 1992; 15: 469-72.
28. Huang MB, Baker CN, Banerjee S, Tenover FC. Accuracy of the E test for determining antimicrobial susceptibilities of Staphylococci, Enterococci, Campylobacter jejuni, and Gram-negative bacteria resistant to antimicrobial agents. J Clin Microbiol 1992; 30: 3243-8.